Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2 [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . U.S. equities were positive in the quarter, with the S&P Index finishing up 4.28%. Class A shares of the fund underperformed the Russell Midcap Growth Index in the quarter. The Communication Services and industrials sectors were the relative contributors while Health Care and Information Technology detracted from the relative performance. In addition, please check the fund's top five holdings to know its best picks in 2024. Alger Mid Cap Growth Fund highlighted stocks like Viking Therapeutics, Inc. (NASDAQ: VKTX ), in the second quarter 2024 investor letter. Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company. The one-month return of Viking Therapeutics, Inc. (NASDAQ:VKTX) was 14.81%, and its shares gained 299.11% of their value over the last 52 weeks. On September 3, 2024, Viking Therapeutics, Inc. (NASDAQ:VKTX) stock closed at $58.39 per share with a market capitalization of $6.469 billion. Alger Mid
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 [Yahoo! Finance]Yahoo! Finance
- Why Investors Plowed Into Viking Therapeutics Stock Today [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.MarketBeat
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website